Consumption of probiotics increases the effect of regulatory T cells in transfer colitis

Inflammatory Bowel Diseases

Volumn 18, Issue 1, 2012, Pages 131-142

  Petersen, Emil Rathsach ^a   Claesson, Mogens Helweg ^a   Schmidt, Esben Gjerløff Wedebye ^a   Jensen, Simon Skjøde ^b   Ravn, Peter ^b   Olsen, Jørgen ^a   Ouwehand, Arthur C ^c   Kristensen, Nanna Ny ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b BIONEER A S   (Denmark)

^c Danisco Finland Oy   (Finland)

Author keywords

colitis; inflammation; probiotics; regulatory T cells

Indexed keywords

CYTOKINE; PROBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL TRANSFER; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; FEEDING; FEMALE; GENE EXPRESSION; IN VIVO CULTURE; INFLAMMATION; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS SALIVARIUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECTUM; REGULATORY T LYMPHOCYTE; SCID MOUSE;

ADMINISTRATION, ORAL; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; COLITIS; CYTOKINES; FEMALE; INFLAMMATION; LACTOBACILLUS; MICE; MICE, INBRED BALB C; MICE, SCID; PROBIOTICS; RECTUM; T-LYMPHOCYTES, REGULATORY;

EID: 83555163699     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21709     Document Type: Article

References (32)

1. Cummings JH,. Dietary carbohydrates and the colonic microflora. Curr Opin Clin Nutr Metab Care. 1998; 1: 409-414. (Pubitemid 128539498)
2. Isolauri E,. Probiotics and gut inflammation. Curr Opin Gastroenterol. 1999; 15: 534.
3. Fooks LJ, Gibson GR,. Probiotics as modulators of the gut flora. Br J Nutr. 2002; 88 (suppl 1): S39-S49. (Pubitemid 35251942)
4. Bengmark S,. Ecological control of the gastrointestinal tract. The role of probiotic flora. Gut. 1998; 42: 2-7. (Pubitemid 28228378)
5. Hart AL, Lammers K, Brigidi P, et al. Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut. 2004; 53: 1602-1609. (Pubitemid 39434103)
6. Gibson GR, Wang X,. Enrichment of bifidobacteria from human gut contents by oligofructose using continuous culture. FEMS Microbiol Lett. 1994; 118: 121-127. (Pubitemid 124012137)
7. Wong JM, de SR, Kendall CW, et al. Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol. 2006; 40: 235-243. (Pubitemid 44309560)
8. Hollander D, Vadheim CM, Brettholz E, et al. Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor. Ann Intern Med. 1986; 105: 883-885. (Pubitemid 17201765)
9. Heller F, Florian P, Bojarski C, et al. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology. 2005; 129: 550-564. (Pubitemid 41096643)
10. Schulzke JD, Bojarski C, Zeissig S, et al. Disrupted barrier function through epithelial cell apoptosis. Ann N Y Acad Sci. 2006; 1072: 288-299. (Pubitemid 44448461)
11. Ukena SN, Singh A, Dringenberg U, et al. Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity. PLoS ONE. 2007; 2: e1308.
12. Foligne B, Nutten S, Grangette C, et al. Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World J Gastroenterol. 2007; 13: 236-243. (Pubitemid 46231326)
13. Paineau D, Carcano D, Leyer G, et al. Effects of seven potential probiotic strains on specific immune responses in healthy adults: a double-blind, randomized, controlled trial. FEMS Immunol Med Microbiol. 2008; 53: 107-113. (Pubitemid 351659718)
14. Schmidt EG, Claesson MH, Jensen SS, et al. Antigen-presenting cells exposed to Lactobacillus acidophilus NCFM, Bifidobacterium bifidum BI-98, and BI-504 reduce regulatory T cell activity. Inflamm Bowel Dis. 2010; 16: 390-400.
15. Daniel C, Poiret S, Goudercourt D, et al. Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model. Appl Environ Microbiol. 2006; 72: 5799-5805. (Pubitemid 44414604)
16. Munder M, Eichmann K, Modolell M,. Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype. J Immunol. 1998; 160: 5347-5354. (Pubitemid 28267823)
17. Roselli M, Finamore A, Nuccitelli S, et al. Prevention of TNBS-induced colitis by different Lactobacillus and Bifidobacterium strains is associated with an expansion of gammadeltaT and regulatory T cells of intestinal intraepithelial lymphocytes. Inflamm Bowel Dis. 2009; 15: 1526-1536.
18. Kwon HK, Lee CG, So JS, et al. Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders. Proc Natl Acad Sci U S A. 2010; 107: 2159-2164.
19. Hacini-Rachinel F, Gheit H, Le Luduec JB, et al. Oral probiotic control skin inflammation by acting on both effector and regulatory T cells. PLoS ONE. 2009; 4: e4903.
20. Moller PL, Paerregaard A, Gad M, et al. Colitic SCID mice fed Lactobacillus spp. show an ameliorated gut histopathology and an altered cytokine profile by local T cells. Inflamm Bowel Dis. 2005; 11: 814-819. (Pubitemid 41368269)
21. Kristensen NN, Brudzewsky D, Gad M, et al. Chemokines involved in protection from colitis by CD4+CD25+ regulatory T cells. Inflamm Bowel Dis. 2006; 12: 612-618. (Pubitemid 43977743)
22. Lavasani S, Dzhambazov B, Nouri M, et al. A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells. PLoS ONE. 2010; 5: e9009.
23. Kristensen NN, Olsen J, Gad M, et al. Genome-wide expression profiling during protection from colitis by regulatory T cells. Inflamm Bowel Dis. 2008; 14: 75-87. (Pubitemid 351196872)
24. Buanne P, Di CE, Caputi L, et al. Crucial pathophysiological role of CXCR2 in experimental ulcerative colitis in mice. J Leukoc Biol. 2007; 82: 1239-1246. (Pubitemid 350133522)
25. Williams EJ, Haque S, Banks C, et al. Distribution of the interleukin-8 receptors, CXCR1 and CXCR2, in inflamed gut tissue. J Pathol. 2000; 192: 533-539.
26. Kristensen NN, Gad M, Thomsen AR, et al. CXC chemokine receptor 3 expression increases the disease-inducing potential of CD4+. Inflamm Bowel Dis. 2006; 12: 374-381.
27. Wang D, Dubois RN, Richmond A,. The role of chemokines in intestinal inflammation and cancer. Curr Opin Pharmacol. 2009; 9: 688-696.
28. Philpott DJ, Girardin SE,. The role of Toll-like receptors and Nod proteins in bacterial infection. Mol Immunol. 2004; 41: 1099-1108. (Pubitemid 39345391)
29. Grabig A, Paclik D, Guzy C, et al. Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways. Infect Immun. 2006; 74: 4075-4082. (Pubitemid 43993340)
30. Hajjar AM, Ernst RK, Tsai JH, et al. Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat Immunol. 2002; 3: 354-359. (Pubitemid 34308623)
31. van Heel DA, Ghosh S, Butler M, et al. Synergistic enhancement of Toll-like receptor responses by NOD1 activation. Eur J Immunol. 2005; 35: 2471-2476. (Pubitemid 41179768)
32. Rachmilewitz D, Katakura K, Karmeli F, et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology. 2004; 126: 520-528. (Pubitemid 38182309)